Platelet functional implications of glycoprotein Ibα polymorphisms in African Americans

Research output: Contribution to journalArticle

Abstract

The platelet glycoprotein Ibα is crucial in the binding of platelets to Von Willebrand Factor within areas of high stress. A single nucleotide polymorphism of GP Ibα gives rise to the Koa (HPA-2b) and the -5C Kozak polymorphism. The presence of these polymorphisms has been associated with an increased risk for atherothrombotic disease. The Koa polymorphism has been shown to have a higher prevalence in African Americans compared to American Caucasians. However, very little is known regarding any functional consequences of these platelet polymorphisms in African Americans. We assessed the prevalence of the Ko and -5C Kozak polymorphisms in a population of both African American and American Caucasian patients with and without CAD and determined whether there were platelet functional consequences in both groups. We studied 99 patients of which 22 were African American and 77 were American Caucasian. Aggregations were performed and shear induced platelet plug formation was tested using a platelet function analyzer. The HPA-2b allele was significantly higher in African Americans when compared to Caucasians (P = 0.001). Genotype frequencies of the -5C Kozak polymorphism were not significantly different between the two groups. We found no differences in platelet aggregation in African Americans who were either heterozygous or homozygous for the HPA-2b allele or the -5C Kozak allele when compared to American Caucasians of the same category. We found no significant differences in PFA-100 testing. We conclude from our study that these polymorphisms do not lead to altered platelet function in African Americans.

Original languageEnglish (US)
Pages (from-to)15-22
Number of pages8
JournalAmerican Journal of Hematology
Volume82
Issue number1
DOIs
StatePublished - Jan 2007

Fingerprint

Platelet Glycoprotein GPIb-IX Complex
African Americans
Blood Platelets
Alleles
Platelet Membrane Glycoproteins
von Willebrand Factor
Platelet Aggregation
Single Nucleotide Polymorphism
Genotype

Keywords

  • Atherosclerosis
  • Glycoproteins
  • Platelets
  • Polymorphisms
  • Race

ASJC Scopus subject areas

  • Hematology

Cite this

Platelet functional implications of glycoprotein Ibα polymorphisms in African Americans. / Williams, Marlene; Ng'alla, Ladina S.; Vaidya, Dhananjay.

In: American Journal of Hematology, Vol. 82, No. 1, 01.2007, p. 15-22.

Research output: Contribution to journalArticle

@article{7ddf28f0c5ff4ef3b978be1b2a41bd7b,
title = "Platelet functional implications of glycoprotein Ibα polymorphisms in African Americans",
abstract = "The platelet glycoprotein Ibα is crucial in the binding of platelets to Von Willebrand Factor within areas of high stress. A single nucleotide polymorphism of GP Ibα gives rise to the Koa (HPA-2b) and the -5C Kozak polymorphism. The presence of these polymorphisms has been associated with an increased risk for atherothrombotic disease. The Koa polymorphism has been shown to have a higher prevalence in African Americans compared to American Caucasians. However, very little is known regarding any functional consequences of these platelet polymorphisms in African Americans. We assessed the prevalence of the Ko and -5C Kozak polymorphisms in a population of both African American and American Caucasian patients with and without CAD and determined whether there were platelet functional consequences in both groups. We studied 99 patients of which 22 were African American and 77 were American Caucasian. Aggregations were performed and shear induced platelet plug formation was tested using a platelet function analyzer. The HPA-2b allele was significantly higher in African Americans when compared to Caucasians (P = 0.001). Genotype frequencies of the -5C Kozak polymorphism were not significantly different between the two groups. We found no differences in platelet aggregation in African Americans who were either heterozygous or homozygous for the HPA-2b allele or the -5C Kozak allele when compared to American Caucasians of the same category. We found no significant differences in PFA-100 testing. We conclude from our study that these polymorphisms do not lead to altered platelet function in African Americans.",
keywords = "Atherosclerosis, Glycoproteins, Platelets, Polymorphisms, Race",
author = "Marlene Williams and Ng'alla, {Ladina S.} and Dhananjay Vaidya",
year = "2007",
month = "1",
doi = "10.1002/ajh.20763",
language = "English (US)",
volume = "82",
pages = "15--22",
journal = "American Journal of Hematology",
issn = "0361-8609",
publisher = "Wiley-Liss Inc.",
number = "1",

}

TY - JOUR

T1 - Platelet functional implications of glycoprotein Ibα polymorphisms in African Americans

AU - Williams, Marlene

AU - Ng'alla, Ladina S.

AU - Vaidya, Dhananjay

PY - 2007/1

Y1 - 2007/1

N2 - The platelet glycoprotein Ibα is crucial in the binding of platelets to Von Willebrand Factor within areas of high stress. A single nucleotide polymorphism of GP Ibα gives rise to the Koa (HPA-2b) and the -5C Kozak polymorphism. The presence of these polymorphisms has been associated with an increased risk for atherothrombotic disease. The Koa polymorphism has been shown to have a higher prevalence in African Americans compared to American Caucasians. However, very little is known regarding any functional consequences of these platelet polymorphisms in African Americans. We assessed the prevalence of the Ko and -5C Kozak polymorphisms in a population of both African American and American Caucasian patients with and without CAD and determined whether there were platelet functional consequences in both groups. We studied 99 patients of which 22 were African American and 77 were American Caucasian. Aggregations were performed and shear induced platelet plug formation was tested using a platelet function analyzer. The HPA-2b allele was significantly higher in African Americans when compared to Caucasians (P = 0.001). Genotype frequencies of the -5C Kozak polymorphism were not significantly different between the two groups. We found no differences in platelet aggregation in African Americans who were either heterozygous or homozygous for the HPA-2b allele or the -5C Kozak allele when compared to American Caucasians of the same category. We found no significant differences in PFA-100 testing. We conclude from our study that these polymorphisms do not lead to altered platelet function in African Americans.

AB - The platelet glycoprotein Ibα is crucial in the binding of platelets to Von Willebrand Factor within areas of high stress. A single nucleotide polymorphism of GP Ibα gives rise to the Koa (HPA-2b) and the -5C Kozak polymorphism. The presence of these polymorphisms has been associated with an increased risk for atherothrombotic disease. The Koa polymorphism has been shown to have a higher prevalence in African Americans compared to American Caucasians. However, very little is known regarding any functional consequences of these platelet polymorphisms in African Americans. We assessed the prevalence of the Ko and -5C Kozak polymorphisms in a population of both African American and American Caucasian patients with and without CAD and determined whether there were platelet functional consequences in both groups. We studied 99 patients of which 22 were African American and 77 were American Caucasian. Aggregations were performed and shear induced platelet plug formation was tested using a platelet function analyzer. The HPA-2b allele was significantly higher in African Americans when compared to Caucasians (P = 0.001). Genotype frequencies of the -5C Kozak polymorphism were not significantly different between the two groups. We found no differences in platelet aggregation in African Americans who were either heterozygous or homozygous for the HPA-2b allele or the -5C Kozak allele when compared to American Caucasians of the same category. We found no significant differences in PFA-100 testing. We conclude from our study that these polymorphisms do not lead to altered platelet function in African Americans.

KW - Atherosclerosis

KW - Glycoproteins

KW - Platelets

KW - Polymorphisms

KW - Race

UR - http://www.scopus.com/inward/record.url?scp=33845915113&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845915113&partnerID=8YFLogxK

U2 - 10.1002/ajh.20763

DO - 10.1002/ajh.20763

M3 - Article

C2 - 16986133

AN - SCOPUS:33845915113

VL - 82

SP - 15

EP - 22

JO - American Journal of Hematology

JF - American Journal of Hematology

SN - 0361-8609

IS - 1

ER -